Cisplatin-based combination chemotherapy
WebApr 12, 2024 · Progression-free survival (PFS) was 8 and 5 months in the cisplatin plus gemcitabine cohort and the gemcitabine cohort (p < .001), respectively. 4 Based on the … WebCisplatin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as an "alkylating agent." (For more detail, see "How Cisplatin Works" section below). What Cisplatin Is Used For: Treatment of advanced bladder cancer, metastatic ovarian cancer, and metastatic testicular cancer.
Cisplatin-based combination chemotherapy
Did you know?
WebMay 23, 2024 · Four common combinations of chemotherapy drugs for SCLC include: cisplatin and etoposide. carboplatin (Paraplatin) and etoposide. cisplatin and irinotecan … WebIntroduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A common side effect of multiday cisplatin chemotherapy is severe nausea and vomiting. Considerable progress has been made in the control of these side effects since the introduction of cisplatin based chemotherapy in the 1970s.
WebJul 1, 2007 · Conclusion: Cisplatin-based chemotherapy during pelvic radiation therapy improves long-term PFS and OS among locally advanced cervical cancer patients … WebCisplatin is a chemotherapy drug used to treat testicular, ovarian, bladder, head and neck, lung and cervical cancer. It may also be used to treat other cancers. It is best to read this …
WebJan 12, 2024 · New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers Scientific Reports Article Open Access … WebSep 3, 2015 · Introduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A common side effect of multiday cisplatin chemotherapy is severe nausea and vomiting. Considerable progress has been made in the control of these side effects since the introduction of cisplatin based chemotherapy in the 1970s.
http://referentiels-aristot.com/wp-content/uploads/08_Soins-de-Support_2024_prise-en-charge-nutritionnelle-moyen-prise-en-charge.pdf
WebAs in the clinic cisplatin is coadministered as a combination with other chemotherapeutic substances, cross-resistance of LTTs towards gemcitabine and doxorubicin was determined. Interestingly, a 16-fold cross-resistance to gemcitabine in RT-112-LTT and a 2.1-fold cross-resistance to doxorubicin in T-24-LTT were observed ( Table S1 ). 2.2. english gunmakers 19th centuryWebComparison of single agent versus combined chemotherapy in previously treated patients with advanced urothelial carcinoma: a meta-analysis Xiao-Jun Wu, Yi Zhi, Peng He, Xiao … dr elizabeth orwick columbus ohWebCisplatin and carboplatin based combinations are not used as an initial therapy. The indications for these two drugs are primary resistant malignant lymphoma and multiple myeloma, or relapses of these diseases not responding to conventional therapy. dr elizabeth orwickWebOct 17, 2012 · Combination cisplatin-based chemotherapy could be a viable option for patients of good performance status with recurrent/metastatic cervical cancer, but further trials that report adequate survival and QoL data are sought. Response rates and improvements in survival are low. Cisplatin-based combinat … dr elizabeth osuchWebCisplatin Vial. - Uses, Side Effects, and More. Cisplatin may cause severe kidney problems, nerve problems, and severe nausea and vomiting. Nerve problems may occur … dr elizabeth ortiz san angeloWebComparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. / Lybol, C; Thomas, CMG; … english gyan odishaWebSep 21, 2016 · Cisplatin-based chemotherapy during pelvic radiation therapy improves long-term PFS and OS among locally advanced cervical cancer patients collectively and … dr. elizabeth orwick columbus ohio